NCT03962660

Brief Summary

This study will evaluate the effectiveness of HaRTS-TRENDS compared to standard care (i.e., brief advice to quit + referral to state quit line that offers free NRT) in facilitating a biochemically verified nonsmoking and b) reducing smoking-related harm as measured by concentration of urinary tobacco-specific nitrosamines (TSNAs). Potential underlying mechanisms of changes in the proposed outcomes--including nicotine craving and smoking reduction, respectively--will be tested.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
94

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 9, 2019

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

May 17, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 24, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2021

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

May 24, 2019

Status Verified

May 1, 2019

Enrollment Period

2 years

First QC Date

May 17, 2019

Last Update Submit

May 22, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Nonsmoking

    Biologically verified nonsmoking (i.e., self-reported nonsmoking if corresponding CO measure is \< 8) in the past 7 days will serve as a primary outcome as well as a potential mediator of the HaRTS-TRENDS effect on TSNA concentration.

    Change across the 12-month follow-up

  • TSNA Concentration

    This primary outcome entails urinary concentration of a tobacco-specific nitrosamine (i.e., NNK), a key carcinogen in tobacco. Secondarily, TSNA concentration will be used as a longer-term biochemical index of tobacco use.

    Change across the 12-month follow-up

Secondary Outcomes (7)

  • smoking intensity

    Change across the 12-month follow-up

  • smoking frequency

    Change across the 12-month follow-up

  • CO level

    Change across the 12-month follow-up

  • cotinine levels

    Change across the 12-month follow-up

  • FEV1%

    Change across the 12-month follow-up

  • +2 more secondary outcomes

Other Outcomes (2)

  • smoking craving

    Change across the 12-month follow-up

  • side effects of ENDS

    Change across the 12-month follow-up

Study Arms (2)

HaRTS-TRENDS

EXPERIMENTAL

See description below.

Other: HaRTS-TRENDS

Standard Care (SC)

ACTIVE COMPARATOR

See description below.

Other: Standard Care (SC)

Interventions

HaRTS-TRENDS comprises 4, individual sessions delivered in the context of the interventionist's pragmatic harm-reduction mindset paired with a compassionate, advocacy-oriented "heart-set" or style. It comprises the delivery of 4 manualized components, including a) participant-led tracking of preferred smoking outcomes, b) elicitation of participants' harm-reduction goals and their progress toward achieving them, c) discussion of the relative risks of various nicotine delivery systems, and d) instruction in using ENDS. Additionally, HaRTS-TRENDS entails provision of commercially available ENDS.

HaRTS-TRENDS

The 4-session, individual standard care control condition entails the well-documented and evidence-based 5 As intervention (i.e., Ask about nicotine use, Assess use, Advise to quit smoking, Assist with exploring current smoking/planning smoking cessation, Arrange follow-up). Part of arranging follow-up is the recommendation to call the smoking quit line, which can supply additional counseling and nicotine replacement therapy.

Also known as: 5 As
Standard Care (SC)

Eligibility Criteria

Age21 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Having a history of chronic homelessness according to the widely accepted federal definition,
  • Being a current DESC client living in one of DESC's participating permanent supportive housing projects,
  • Being between 21-65 years of age,
  • Being a daily smoker (\>4 cigarettes/day in the past year with a breath CO ≥ 6 ppm or salivary cotinine test at level 1 if CO \< 6 ppm)
  • Having adequate English language skills to understand verbal information and communicate in the study

You may not qualify if:

  • Use of other tobacco products besides cigarettes ≥ 9 days in the past month
  • Refusal or inability to consent to participation in research
  • Constituting a risk to the safety and security of other clients or staff.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Washington - Harborview Medical Center

Seattle, Washington, 98195, United States

RECRUITING

MeSH Terms

Conditions

Tobacco Smoking

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

SmokingBehaviorTobacco Use

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Susan E Collins, PhD

    University of Washington

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tatiana M Ubay

CONTACT

Emily Taylor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: HaRTS-TRENDS, in which participants will attend 4, 30-minute sessions with research staff. They will discuss participants' current smoking and their goals around reducing smoking-related harm and improving their health-related quality of life. Participants will also engage in discussions about the safety profiles of different nicotine products. One group of these products, e-cigarettes, is 95% safer than smoking and will be made available to participants to help them achieve their harm-reduction goals. They will receive instructions and demonstrations for its safe and proper use. -OR- Standard care, in which will attend 4, 30-minute sessions of brief advice to quit.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, School of Medicine: Psychiatry

Study Record Dates

First Submitted

May 17, 2019

First Posted

May 24, 2019

Study Start

May 9, 2019

Primary Completion

April 30, 2021

Study Completion

December 31, 2021

Last Updated

May 24, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

The proposed research will involve people recruited from prominent Housing First programs serving chronically homeless people who are often multiply affected by psychiatric, medical and substance-use disorders. The proposed sample will be recruited from a highly vulnerable and marginalized population in a tight-knit urban community. Furthermore, the partnering agency is well-known for its housing approach, and regularly conducts tours to help inform other housing providers, policy makers, and other public stakeholders about this model to promote replicability. Thus, even with the removal of all identifiers, we believe that it could become difficult to fully protect the identities of participants and their data (including e-cigarette use and smoking which are not currently allowed in housing). For these reasons, we do not have immediate plans to share the data collected in the context of the proposed study.

Locations